Working with the media
ANZCA has an experienced communications team that proactively engages with the media to highlight the important work of our anaesthetists and pain specialists. This includes sharing our latest evidence-based research and patient safety initiatives. We also actively encourage m...
Find out more
About the ANZCA Clinical Trials Network
Our clinical trials seek definitive answers to inform best practice and improve patient care and safety. Explore who we are; our strategic priorities; our history and funding achievements; major findings from our published trials; and important research questions underway.
Find out more
Smoking and anaesthesia factsheet
Pain-medicine-stories-by-the-ABC-and-The-Age-joint-winners-of-ANZCA-Media-Award-28-Feb-2019
ANZCA Pholcodine Statement September 2023
Recall of pholcodine - Pholcodine Statement
ANZCA Pholcodine Statement September 2023
This statement has been prepared in response to the decision of the Australian Government
Therapeutic Goods Administration (TGA) to withdraw pholcodine-containing products from the market. Evidence shows that pholcodine consumption in the 12-month period prior to a general an...
PS40(G)BP Position statement on relationship between fellows, trainees and healthcare industry BP
PS40(G)BP Position statement on the relationship between fellows, trainees and the healthcare industry Background Paper
PoM communique October2019